Literature DB >> 28139442

13-valent pneumococcal conjugate vaccine in Africa.

Robert Cohen1, Corinne Levy2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28139442     DOI: 10.1016/S2214-109X(17)30044-X

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  3 in total

1.  Pneumococcus nasopharyngeal carriage in children attending an academic hospital in Pretoria, South Africa, after the introduction of pneumococcal vaccine.

Authors:  Charity Newton; Harry Maake; Caroline Maluleka; Siyazi Mda
Journal:  S Afr J Infect Dis       Date:  2019-10-22

2.  The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults.

Authors:  Charles Feldman; Sipho K Dlamini; Shabir A Madhi; Susan Meiring; Anne von Gottberg; Janetta C de Beer; Margreet de Necker; Marthinus P Stander
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

3.  Phylogeography and resistome of pneumococcal meningitis in West Africa before and after vaccine introduction.

Authors:  Madikay Senghore; Peggy-Estelle Tientcheu; Archibald Kwame Worwui; Sheikh Jarju; Catherine Okoi; Sambou M S Suso; Ebenezer Foster-Nyarko; Chinelo Ebruke; Mohamadou Sonko; Mamdou Hama Kourna; Joseph Agossou; Enyonam Tsolenyanu; Lorna Awo Renner; Daniel Ansong; Bakary Sanneh; Catherine Boni Cisse; Angeline Boula; Berthe Miwanda; Stephanie W Lo; Rebecca A Gladstone; Stephanie Schwartz; Paulina Hawkins; Lesley McGee; Keith P Klugman; Robert F Breiman; Stephen D Bentley; Jason M Mwenda; Brenda Anna Kwambana-Adams; Martin Antonio
Journal:  Microb Genom       Date:  2021-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.